Clinical Trial Update: Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating NC-6004 in combination with gemcitabine versus gemcitabine alone in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• Gemcitabine (Gemcitabine)
• NC-6004 (cisplatin nanoparticle formulation)

Snippet

Sponsor: Orient Europharma Co., Ltd. | Conditions: Pancreatic Neoplasms | Phase 3 | Status: COMPLETED